Skip to content
team-nb Logo
  • TEAM-NB
  • ABOUT US
  • MEMBERS
  • LINKS
  • FAQ
  • CONTACT
Previous Next

Art 10a Information by manufacturer in case of interruption or discontinuation of supply

09
Dec
2024

The Q&A is available on the Commission web site.

Link : https://health.ec.europa.eu/document/download/b431b10f-8512-4f47-9191-e1b84b2f9a27_en?filename=mdr_qna-article10a_mdr-ivdr_en.pdf

pascaleperspectives2025-02-17T04:44:30+01:00

Articles Récents

  • TEAM NB Position Paper on Clinical Evaluation Based on Non-Clinical Data
  • TEAM NB Position Paper on BPG for the Submission of TD – V4
  • MDR Clinical Training for Manufacturers
  • Code of Conduct – Version 5.2
  • Team-NB is a partner of MedTechLabel EU project.
  • NBCG-Med
  • RAPS interview
  • The director of Team-NB was interviewed by Magdalena Kensy, a health journalist at EURACTIV
  • Medtech Insight article : EU Notified Bodies Say MDR/IVDR Proposals Would Carry Increased Risk To Public Health
  • MDR/IVDR revision: Team-NB feedback
© Copyright | privacy policy | All Rights Reserved | Private Part | Team-NB Documents
LinkedInRss
Page load link
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Go to Top